Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MOLINA HEALTHCARE, INC.

(MOH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Molina Healthcare : Reports Second Quarter 2021 Financial Results

07/28/2021 | 04:17pm EDT

Increases Full Year 2021 Earnings Guidance

Molina Healthcare, Inc. (NYSE: MOH) (the “Company”) today reported second quarter of 2021 GAAP earnings per diluted share of $3.16 and adjusted earnings per diluted share of $3.40. Financial results are summarized below:

 

 

Quarter ended

 

Six months ended

 

June 30,

 

June 30,

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

(In millions, except per-share results)

Premium Revenue

$6,583

 

$4,372

 

$12,889

 

$8,676

Total Revenue

$6,800

 

$4,618

 

$13,322

 

$9,167

 

 

 

 

 

 

 

 

GAAP:

 

 

 

 

 

 

 

Net Income

$185

 

$276

 

$413

 

$454

EPS – Diluted

$3.16

 

$4.65

 

$7.05

 

$7.54

Medical Care Ratio (MCR)

88.4%

 

82.3%

 

87.6%

 

84.3%

G&A Ratio

7.1%

 

7.5%

 

7.2%

 

7.2%

After-tax Margin

2.7%

 

6.0%

 

3.1%

 

5.0%

 

 

 

 

 

 

 

 

Adjusted:

 

 

 

 

 

 

 

Net Income

$199

 

$285

 

$459

 

$469

EPS – Diluted

$3.40

 

$4.79

 

$7.83

 

$7.79

G&A Ratio

6.9%

 

7.5%

 

7.0%

 

7.2%

After-tax Margin

2.9%

 

6.2%

 

3.4%

 

5.1%

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Quarter Highlights

  • GAAP net income for the second quarter of 2021 was $185 million, or $3.16 per diluted share.
  • Adjusted net income for the second quarter of 2021 was $199 million, or $3.40 per diluted share.
  • As of June 30, 2021, the Company served approximately 4.7 million members, an increase of 1.1 million members, or 32%, compared to June 30, 2020.
  • Premium revenue was approximately $6.6 billion for the second quarter of 2021, an increase of 51% compared to the second quarter of 2020.
  • The net effect of COVID decreased net income by approximately $1.00 per diluted share in the second quarter of 2021.
  • The Company increased its full year 2021 premium revenue guidance to more than $25.0 billion, from its previous guidance of more than $24.0 billion.
  • The Company increased its full year 2021 adjusted earnings guidance to no less than $13.25 per diluted share, from its previous guidance of no less than $13.00 per diluted share.

“We are pleased with our second quarter and year to date results as we continue to produce solid margin performance despite the challenges created by the pandemic,” said Joseph Zubretsky, president and CEO of Molina Healthcare. “We accomplished this while generating approximately 50% year-over-year premium revenue growth and successfully integrating businesses representing approximately $5 billion in annual revenue.”

Premium Revenue
Premium revenue was approximately $6.6 billion for the second quarter of 2021, an increase of 51% compared to the second quarter of 2020. The higher premium revenue reflects increased organic membership in Medicaid, Medicare, and Marketplace, along with the impact of acquisitions that closed in the second half of 2020.

Net Income
Net income for the second quarter was $185 million, or $3.16 per diluted share, compared to $276 million, or $4.65 per diluted share in the second quarter of 2020. Adjusted net income for the second quarter was $199 million, or $3.40 per diluted share, compared to $285 million, or $4.79 per diluted share in the second quarter of 2020.

The year over year comparison reflects the negative impact from the net effect of COVID in the second quarter of 2021 while, in contrast, the prior year quarter was positively impacted by the net effect of COVID.

Net income for the six months ended June 30, 2021 was $413 million, or $7.05 per diluted share, compared to $454 million, or $7.54 per diluted share in the six months ended June 30, 2020. Adjusted net income for the six months ended June 30, 2021 was $459 million, or $7.83 per diluted share, compared to $469 million, or $7.79 per diluted share in the six months ended June 30, 2020.

Medical Care Ratio
The consolidated MCR for the second quarter was 88.4%, compared to 82.3% in the second quarter of 2020. The net effect of COVID increased the consolidated MCR by 110 basis points and impacted all three lines of business. In the prior year, the net effect of COVID decreased the consolidated MCR by approximately 350 basis points.

A year-over-year comparison is less meaningful than it would be in a typical year. The second quarter of 2020 was the first full quarter of the COVID pandemic, and was distorted by the significant positive net effect of COVID that characterized that early phase of the crisis. In contrast, the current quarter was negatively impacted by the net effect of COVID. Therefore, a sequential MCR comparison is more relevant.

On a sequential basis, the consolidated MCR for the second quarter was 88.4%, compared to 86.8% in the first quarter of 2021. The net effect of COVID increased the consolidated MCR by 110 basis points in the second quarter of 2021 and was negligible the first quarter.

  • Medicaid MCR: Increased to 89.0% compared to 87.5% for the first quarter of 2021. The increase in the MCR was primarily due to the net effect of COVID.
  • Medicare MCR: Decreased to 87.6% compared to 90.3% in the first quarter of 2021. The decrease in the MCR was primarily due to the lower negative net effect of COVID and improved underlying performance compared to the first quarter.
  • Marketplace MCR: Increased to 84.8% compared to 77.3% for the first quarter of 2021. The impact from the net effect of COVID in the second quarter was approximately 500 basis points, consistent with the first quarter, due to continued COVID utilization pressure in many geographies. The sequential increase in the MCR primarily reflects normal seasonality.

General and Administrative Expense Ratio
The G&A ratio for the second quarter was 7.1%, compared to 7.5% for the second quarter of 2020. The adjusted G&A ratio for the second quarter was 6.9%, compared to 7.5% for the second quarter of 2020 reflecting disciplined cost management and the benefits of fixed cost leverage produced by substantial revenue growth.

Balance Sheet
Cash and investments at the parent company amounted to $564 million as of June 30, 2021, compared to $644 million as of December 31, 2020. The decline was primarily due to the Company’s share repurchase program.

Cash Flow
Operating cash flow for the six months ended June 30, 2021 amounted to $1,061 million and was higher compared to the six months ended June 30, 2020, primarily due to growth in operations and the net impact of timing differences in governmental receivables and payables.

2021 Guidance
The Company now expects its full year 2021 total revenue to be more than $26.0 billion, compared to the previous guidance of more than $25.0 billion, an increase of approximately 34% from the full year 2020.

Premium revenue guidance is now expected to be more than $25.0 billion, compared to the previous guidance of more than $24.0 billion, an increase of approximately 37% from the full year 2020.

The Company increased its full year 2021 adjusted earnings per share guidance to be no less than $13.25 per share, compared to the previous guidance of no less than $13.00.

Revised guidance reflects:

  • Updated assumptions for the Public Health Emergency period, and the associated pause on Medicaid membership redeterminations, which is now expected to continue through the fourth quarter of 2021;
  • Retention of pharmacy related premium in California, New York, and Kentucky;
  • Underlying outperformance;
  • Offset by an increase in the estimated net effect of COVID by $1.00 per share which is now expected to be approximately $2.50 per share for the full year; and
  • Continued caution in forecasting utilization trends in the remaining six months of the year due to the COVID pandemic.

The impact of the Affinity and the Cigna Texas membership acquisitions are not included.

See the Reconciliation of Unaudited Non-GAAP Financial Measures at the end of this release.

Conference Call
Management will host a conference call and webcast to discuss Molina Healthcare’s second quarter 2021 results at 8:00 a.m. Eastern Time on Thursday, July 29, 2021. The number to call for the interactive teleconference is (877) 883-0383 and the confirmation number is 5686734. A telephonic replay of the conference call will be available through Thursday, August 12, 2021, by dialing (877) 344-7529 and entering confirmation number 10157375. A live audio broadcast of this conference call will be available on Molina Healthcare’s website, molinahealthcare.com. A 30-day online replay will be available approximately an hour following the conclusion of the live broadcast.

About Molina Healthcare
Molina Healthcare, Inc., a FORTUNE 500 company, provides managed healthcare services under the Medicaid and Medicare programs and through the state insurance marketplaces. Through its locally operated health plans, Molina Healthcare served approximately 4.7 million members as of June 30, 2021. For more information about Molina Healthcare, please visit molinahealthcare.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This earnings release and the Company’s accompanying oral remarks contain forward-looking statements regarding its 2021 guidance, as well as its plans, expectations, and the Company’s expectations regarding future developments. Actual results could differ materially due to numerous known and unknown risks and uncertainties. These risks and uncertainties are discussed under the headings “Forward-Looking Statements,” and “Risk Factors,” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, which is on file with the SEC, and also in its Quarterly Report on Form 10-Q for the period ended June 30, 2021, which the Company expects to file on or about July 29, 2021.

These reports can be accessed under the investor relations tab of the Company’s website or on the SEC’s website at sec.gov. Given these risks and uncertainties, the Company can give no assurances that its forward-looking statements will prove to be accurate, or that any other results or developments projected or contemplated by its forward-looking statements will in fact occur, and the Company cautions investors not to place undue reliance on these statements. All forward-looking statements in this release represent the Company’s judgment as of July 28, 2021, and, except as otherwise required by law, the Company disclaims any obligation to update any forward-looking statement to conform the statement to actual results or changes in its expectations.

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONSOLIDATED STATEMENTS OF INCOME

 

 

Three Months Ended

 

Six Months Ended

 

June 30,

 

June 30,

 

2021

 

2020

 

2021

 

2020

 

 

 

 

 

 

 

 

 

(In millions, except per-share amounts)

Revenue:

 

 

 

 

 

 

 

Premium revenue

$

6,583

 

 

$

4,372

 

 

$

12,889

 

 

$

8,676

 

Premium tax revenue

185

 

 

157

 

 

372

 

 

307

 

Health insurer fees reimbursed

 

 

71

 

 

 

 

137

 

Investment income

10

 

 

13

 

 

19

 

 

38

 

Other revenue

22

 

 

5

 

 

42

 

 

9

 

Total revenue

6,800

 

 

4,618

 

 

13,322

 

 

9,167

 

Operating expenses:

 

 

 

 

 

 

 

Medical care costs

5,819

 

 

3,598

 

 

11,293

 

 

7,314

 

General and administrative expenses

484

 

 

345

 

 

957

 

 

662

 

Premium tax expenses

185

 

 

157

 

 

372

 

 

307

 

Health insurer fees

 

 

71

 

 

 

 

139

 

Depreciation and amortization

31

 

 

21

 

 

64

 

 

41

 

Other

8

 

 

2

 

 

28

 

 

6

 

Total operating expenses

6,527

 

 

4,194

 

 

12,714

 

 

8,469

 

Operating income

273

 

 

424

 

 

608

 

 

698

 

Other expenses, net:

 

 

 

 

 

 

 

Interest expense

30

 

 

24

 

 

60

 

 

45

 

Other expense, net

 

 

5

 

 

 

 

5

 

Total other expenses, net

30

 

 

29

 

 

60

 

 

50

 

Income before income tax expense

243

 

 

395

 

 

548

 

 

648

 

Income tax expense

58

 

 

119

 

 

135

 

 

194

 

Net income

$

185

 

 

$

276

 

 

$

413

 

 

$

454

 

 

 

 

 

 

 

 

 

Net income per share – Diluted

$

3.16

 

 

$

4.65

 

 

$

7.05

 

 

$

7.54

 

 

 

 

 

 

 

 

 

Diluted weighted average shares outstanding

58.4

 

 

59.4

 

 

58.5

 

 

60.2

 

 

 

 

 

 

 

 

 

Operating Statistics:

 

 

 

 

 

 

 

Medical care ratio

88.4

%

 

82.3

%

 

87.6

%

 

84.3

%

G&A ratio

7.1

%

 

7.5

%

 

7.2

%

 

7.2

%

Premium tax ratio

2.7

%

 

3.5

%

 

2.8

%

 

3.4

%

Effective income tax rate

24.2

%

 

30.0

%

 

24.7

%

 

29.9

%

After-tax margin

2.7

%

 

6.0

%

 

3.1

%

 

5.0

%

 

 

 

 

 

 

 

 

 

MOLINA HEALTHCARE, INC.

CONSOLIDATED BALANCE SHEETS

 

 

June 30,

 

December 31,

 

2021

 

2020

 

Unaudited

 

 

 

(Dollars in millions,

except per-share amounts)

ASSETS

Current assets:

 

 

 

Cash and cash equivalents

$

4,608

 

 

$

4,154

 

Investments

2,241

 

 

1,875

 

Receivables

1,857

 

 

1,672

 

Prepaid expenses and other current assets

168

 

 

175

 

Total current assets

8,874

 

 

7,876

 

Property, equipment, and capitalized software, net

383

 

 

391

 

Goodwill and intangible assets, net

929

 

 

941

 

Restricted investments

145

 

 

136

 

Deferred income taxes

65

 

 

69

 

Other assets

134

 

 

119

 

Total assets

$

10,530

 

 

$

9,532

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ EQUITY

Current liabilities:

 

 

 

Medical claims and benefits payable

$

2,942

 

 

$

2,696

 

Amounts due government agencies

2,072

 

 

1,253

 

Accounts payable, accrued liabilities and other

651

 

 

641

 

Deferred revenue

42

 

 

375

 

Total current liabilities

5,707

 

 

4,965

 

Long-term debt

2,129

 

 

2,127

 

Finance lease liabilities

223

 

 

225

 

Other long-term liabilities

101

 

 

119

 

Total liabilities

8,160

 

 

7,436

 

Stockholders’ equity:

 

 

 

Common stock, $0.001 par value, 150 million shares authorized; outstanding: 58 million shares at June 30, 2021, and 59 million shares at December 31, 2020

 

 

 

Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding

 

 

 

Additional paid-in capital

191

 

 

199

 

Accumulated other comprehensive income

26

 

 

37

 

Retained earnings

2,153

 

 

1,860

 

Total stockholders’ equity

2,370

 

 

2,096

 

Total liabilities and stockholders’ equity

$

10,530

 

 

$

9,532

 

 

 

 

 

 

MOLINA HEALTHCARE, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

Six Months Ended

 

June 30,

 

2021

 

2020

 

 

 

 

 

(in millions)

Operating activities:

 

 

 

Net income

$

413

 

 

$

454

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

Depreciation and amortization

64

 

 

41

 

Deferred income taxes

7

 

 

6

 

Share-based compensation

35

 

 

28

 

Loss on debt repayment

 

 

5

 

Other, net

10

 

 

(1)

 

Changes in operating assets and liabilities:

 

 

 

Receivables

(192)

 

 

(174)

 

Prepaid expenses and other current assets

(6)

 

 

(157)

 

Medical claims and benefits payable

272

 

 

106

 

Amounts due government agencies

792

 

 

201

 

Accounts payable, accrued liabilities and other

(15)

 

 

259

 

Deferred revenue

(333)

 

 

(195)

 

Income taxes

14

 

 

184

 

Net cash provided by operating activities

1,061

 

 

757

 

Investing activities:

 

 

 

Purchases of investments

(1,006)

 

 

(670)

 

Proceeds from sales and maturities of investments

622

 

 

750

 

Purchases of property, equipment, and capitalized software

(29)

 

 

(45)

 

Other, net

5

 

 

3

 

Net cash (used in) provided by investing activities

(408)

 

 

38

 

Financing activities:

 

 

 

Common stock purchases

(128)

 

 

(453)

 

Common stock withheld to settle employee tax obligations

(52)

 

 

(8)

 

Contingent consideration liabilities settled

(20)

 

 

 

Proceeds from senior notes offering, net of issuance costs

 

 

789

 

Repayment of term loan facility

 

 

(600)

 

Proceeds from borrowings under term loan facility

 

 

380

 

Other, net

 

 

(45)

 

Net cash (used in) provided by financing activities

(200)

 

 

63

 

Net increase in cash, cash equivalents, and restricted cash and cash equivalents

453

 

 

858

 

Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period

4,223

 

 

2,508

 

Cash, cash equivalents, and restricted cash and cash equivalents at end of period

$

4,676

 

 

$

3,366

 

 

 

 

 

 

MOLINA HEALTHCARE, INC.

UNAUDITED SEGMENT DATA

(Dollars in millions)

 

 

 

June 30,

 

December 31,

 

June 30,

 

 

2021 (1)

 

2020

 

2020

Ending Membership by Segment:

 

 

 

 

 

Medicaid

3,928,000

 

 

3,599,000

 

 

3,122,000

 

Medicare

130,000

 

 

115,000

 

 

108,000

 

Marketplace

638,000

 

 

318,000

 

 

325,000

 

Total

4,696,000

 

 

4,032,000

 

 

3,555,000

 

 

 

 

 

 

 

 

(1) Approximately 200,000 members, from the Magellan Complete Care acquisition that closed on December 31, 2020, are included in the totals as of June 30, 2021, but not in prior periods.

 

 

Three Months Ended March 31,

 

2021

 

2020

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

4,840

 

 

$

604

 

 

87.5

%

 

$

3,286

 

 

$

365

 

 

88.9

%

Medicare

799

 

 

77

 

 

90.3

 

 

634

 

 

117

 

 

81.7

 

Marketplace

667

 

 

151

 

 

77.3

 

 

384

 

 

106

 

 

72.3

 

Consolidated

$

6,306

 

 

$

832

 

 

86.8

%

 

$

4,304

 

 

$

588

 

 

86.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended June 30,

 

2021

 

2020

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

5,034

 

 

$

551

 

 

89.0

%

 

$

3,375

 

 

$

553

 

 

83.6

%

Medicare

814

 

 

101

 

 

87.6

 

 

630

 

 

125

 

 

80.0

 

Marketplace

735

 

 

112

 

 

84.8

 

 

367

 

 

96

 

 

74.0

 

Consolidated

$

6,583

 

 

$

764

 

 

88.4

%

 

$

4,372

 

 

$

774

 

 

82.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Six Months Ended June 30,

 

2021

 

2020

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

Premium
Revenue

 

Medical

Margin

 

MCR (1)

 

 

 

 

 

 

Medicaid

$

9,874

 

 

$

1,155

 

 

88.3

%

 

$

6,661

 

 

$

918

 

 

86.2

%

Medicare

1,613

 

 

178

 

 

89.0

 

 

1,264

 

 

242

 

 

80.8

 

Marketplace

1,402

 

 

263

 

 

81.2

 

 

751

 

 

202

 

 

73.1

 

Consolidated

$

12,889

 

 

$

1,596

 

 

87.6

%

 

$

8,676

 

 

$

1,362

 

 

84.3

%

 

 

 

 

 

 

 

 

 

 

 

 

(1) The MCR represents medical costs as a percentage of premium revenue.

MOLINA HEALTHCARE, INC.
CHANGE IN MEDICAL CLAIMS AND BENEFITS PAYABLE
(Dollars in millions)

The Company’s claims liabilities include additional reserves to account for moderately adverse conditions based on historical experience and other factors including, but not limited to, variations in claims payment patterns, changes in utilization and cost trends, known outbreaks of disease, and large claims. The Company’s reserving methodology is consistently applied across all periods presented. The amounts displayed for “Components of medical care costs related to: Prior year” represent the amounts by which the original estimates of claims and benefits payable at the beginning of the year were more than the actual liabilities based on information (principally the payment of claims) developed since those liabilities were first reported. The following table presents the components of the change in medical claims and benefits payable for the periods indicated:

 

 

Six Months Ended

 

June 30,

 

2021

 

2020

 

 

 

 

 

Unaudited

Medical claims and benefits payable, beginning balance

$

2,696

 

 

$

1,854

 

Components of medical care costs related to:

 

 

 

Current year

11,486

 

 

7,372

 

Prior year

(193)

 

 

(58)

 

Total medical care costs

11,293

 

 

7,314

 

Payments for medical care costs related to:

 

 

 

Current year

9,023

 

 

5,688

 

Prior year

1,949

 

 

1,486

 

Total paid

10,972

 

 

7,174

 

Change in acquired balances

(26)

 

 

 

Change in non-risk and other provider payables

(49)

 

 

(34)

 

Medical claims and benefits payable, ending balance

$

2,942

 

 

$

1,960

 

 

 

 

 

Days in claims payable, fee for service (1)

48

 

 

52

 

__________________

 

 

 

(1) Claims payable includes primarily claims incurred but not paid, or IBNP. It also includes certain fee-for-service payables reported in medical claims and benefits payable amounting to $110 million and $71 million, as of June 30, 2021, and 2020, respectively.

MOLINA HEALTHCARE, INC.
RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES
(In millions, except per diluted share amounts)

The Company believes that certain non-GAAP (generally accepted accounting principles) financial measures are useful supplemental measures to investors in comparing the Company’s performance to the performance of other public companies in the health care industry. The non-GAAP financial measures are also used internally to enable management to assess the Company’s performance consistently over time. These non-GAAP financial measures, presented below, should be considered as supplements to, and not as substitutes for or superior to, GAAP measures.

Adjustments represent additions and deductions to GAAP net income as indicated in the table below, which include the non-cash impact of amortization of acquired intangible assets, acquisition-related expenses, and the impact of certain expenses and other items that management believes are not indicative of longer-term business trends and operations.

Adjusted G&A Ratio represents the GAAP G&A ratio, recognizing adjustments.

Adjusted net income represents GAAP net income recognizing the adjustments, net of tax. The Company believes that adjusted net income is helpful to investors in assessing the Company’s financial performance.

Adjusted net income per diluted share represents adjusted net income divided by weighted average common shares outstanding on a fully diluted basis.

Adjusted after-tax margin represents adjusted net income, divided by total revenue.

 

 

Three Months Ended June 30,

 

Six Months Ended June 30,

2021

 

2020

 

2021

 

2020

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

 

Amount

 

Per
Diluted
Share

Net income

$

185

 

 

$

3.16

 

 

$

276

 

 

$

4.65

 

 

$

413

 

 

$

7.05

 

 

$

454

 

 

$

7.54

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition-related expenses (1)

6

 

 

0.11

 

 

 

 

 

 

27

 

 

0.46

 

 

 

 

 

Amortization of intangible assets

12

 

 

0.20

 

 

4

 

 

0.06

 

 

24

 

 

0.40

 

 

8

 

 

0.13

 

Loss on debt repayment

 

 

 

 

5

 

 

0.08

 

 

 

 

 

 

5

 

 

0.08

 

Other (2)

 

 

 

 

2

 

 

0.04

 

 

9

 

 

0.16

 

 

6

 

 

0.11

 

Subtotal, adjustments

18

 

 

0.31

 

 

11

 

 

0.18

 

 

60

 

 

1.02

 

 

19

 

 

0.32

 

Income tax effect

(4)

 

 

(0.07)

 

 

(2)

 

 

(0.04)

 

 

(14)

 

 

(0.24)

 

 

(4)

 

 

(0.07)

 

Adjustments, net of tax

14

 

 

0.24

 

 

9

 

 

0.14

 

 

46

 

 

0.78

 

 

15

 

 

0.25

 

Adjusted net income

$

199

 

 

$

3.40

 

 

$

285

 

 

$

4.79

 

 

$

459

 

 

$

7.83

 

 

$

469

 

 

$

7.79

 

__________________

(1) Beginning in the third quarter of 2020, reflects non-recurring costs associated with acquisitions, including various transaction and integration costs.
(2) The first half of 2021 includes change in premium deficiency reserves, loss on sale of property, and restructuring costs. The first half of 2020 includes restructuring costs.

 

 

MOLINA HEALTHCARE, INC.

RECONCILIATION OF UNAUDITED NON-GAAP FINANCIAL MEASURES (CONTINUED)

2021 GUIDANCE

 

Net income per diluted share (1)

$

11.65

 

Adjustments:

 

Acquisition-related expenses

1.13

 

Amortization of intangible assets

0.81

 

Other

0.16

 

Subtotal, adjustments

2.10

 

Income tax effect (2)

(0.50)

 

Adjustments, net of tax

1.60

 

Adjusted net income per diluted share

$

13.25

 

__________________

(1) Computations assume approximately 58.6 million diluted weighted average shares outstanding.
(2) Income tax effect calculated at the statutory tax rate of 23.8%.

 


© Business Wire 2021
All news about MOLINA HEALTHCARE, INC.
09/17MOLINA HEALTHCARE : Projects Higher Premium Revenue for 2022; Shares Up
MT
09/17MOLINA HEALTHCARE, INC. : Regulation FD Disclosure, Financial Statements and Exh..
AQ
09/17MOLINA HEALTHCARE : 2021 Investor Day Presentation
PU
09/13MOLINA HEALTHCARE : Announces Third Quarter 2021 Earnings Release and Conference..
BU
09/09MOLINA HEALTHCARE : Signs CEO Joe Zubretsky to New Employment Agreement (Form 8-..
PU
09/09MOLINA HEALTHCARE, INC. : Entry into a Material Definitive Agreement, Change in ..
AQ
09/09MOLINA HEALTHCARE : Signs CEO Joe Zubretsky to New Employment Agreement
BU
09/01MOLINA HEALTHCARE : Am I eligible for Medicaid?
PU
08/31MOLINA HEALTHCARE : Morgan Stanley Adjusts Molina Healthcare's Price Target to $..
MT
08/23Molina Healthcare Announces Appointment of Jennifer Vermeer as Plan President..
CI
More news
Analyst Recommendations on MOLINA HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2021 26 587 M - -
Net income 2021 710 M - -
Net cash 2021 5 588 M - -
P/E ratio 2021 22,4x
Yield 2021 -
Capitalization 16 243 M 16 243 M -
EV / Sales 2021 0,40x
EV / Sales 2022 0,28x
Nbr of Employees 10 500
Free-Float 99,1%
Chart MOLINA HEALTHCARE, INC.
Duration : Period :
Molina Healthcare, Inc. Technical Analysis Chart | MOH | US60855R1005 | MarketScreener
Technical analysis trends MOLINA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 14
Last Close Price 278,14 $
Average target price 287,15 $
Spread / Average Target 3,24%
EPS Revisions
Managers and Directors
Joseph M. Zubretsky President, Chief Executive Officer & Director
Mark L. Keim Chief Financial Officer
Dale B. Wolf Chairman
Jason Dees Chief Medical Officer
Ronna E. Romney Vice Chairman
Sector and Competitors
1st jan.Capi. (M$)
MOLINA HEALTHCARE, INC.30.78%16 243
UNITEDHEALTH GROUP18.87%396 176
ANTHEM, INC.16.77%92 533
CIGNA CORPORATION-1.28%69 933
HUMANA INC.-2.71%52 403
CENTENE CORPORATION7.68%37 688